Profile data is unavailable for this security.
About the company
Entero Healthcare Solutions Ltd is an India-based company, which provides software and services to the healthcare industry. The Company's segments include Software and Services. Software segment includes the development and implementation of software solutions for hospitals, clinics, ambulatory surgery centers (ASCs), and other healthcare facilities. Services segment consists of the provision of consulting services, including project management, business process outsourcing (BPO) and human resource management (HRM).
- Revenue in INR (TTM)--
- Net income in INR--
- Incorporated2018
- Employees3.24k
- LocationEntero Healthcare Solutions LtdMUMBAI 400051IndiaIND
- Phone+91 2 269019100
- Websitehttps://www.enterohealthcare.com/
More ▼
Mergers & acquisitions
| Acquired company | ENTERO:NSI since announced | Transaction value |
|---|---|---|
| Getwell Medicare Solution Pvt Ltd | 31.32% | 145.00k |
Data delayed at least 15 minutes, as of Sep 27 2024 11:27 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eiken Chemical Co Ltd | 22.93bn | 1.36bn | 53.87bn | 757.00 | 37.89 | 1.84 | 19.94 | 2.35 | 63.86 | 63.86 | 1,090.26 | 1,318.52 | 0.6279 | 2.76 | 3.41 | 52,453,100.00 | 3.71 | 8.01 | 4.53 | 10.14 | 41.54 | 45.92 | 5.92 | 11.50 | 2.39 | -- | 0.0617 | 35.45 | -7.44 | 2.29 | -54.08 | -5.24 | 11.66 | 11.20 |
| Shanghai INT Medical Instruments Co Ltd | 9.59bn | 2.10bn | 54.11bn | 1.73k | 24.66 | 2.71 | 18.89 | 5.65 | 1.16 | 1.16 | 5.27 | 10.56 | 0.4128 | 2.08 | 12.01 | 569,012.90 | 8.81 | 8.63 | 10.41 | 9.76 | 60.16 | 59.44 | 21.34 | 26.16 | 2.06 | -- | 0.0384 | 31.80 | 28.50 | 29.96 | 18.79 | 21.76 | 45.75 | -- |
| Japan Lifeline Co., Ltd. | 30.29bn | 4.35bn | 54.21bn | 1.22k | 12.33 | 1.66 | 10.33 | 1.79 | 100.47 | 100.47 | 698.85 | 747.22 | 0.7513 | 1.42 | 3.84 | 43,125,000.00 | 10.78 | 8.63 | 13.40 | 10.88 | 60.42 | 57.28 | 14.35 | 12.28 | 1.55 | -- | 0.1169 | 48.80 | -0.7073 | 2.45 | 9.06 | -0.5446 | 5.40 | 7.69 |
| Jiangsu Bioperfectus Technologies Co Ltd | 4.70bn | -3.30bn | 55.73bn | 684.00 | -- | 1.36 | -- | 11.86 | -4.71 | -4.71 | 6.72 | 58.59 | 0.0943 | 0.8778 | 1.90 | 576,042.20 | -6.61 | 25.41 | -7.42 | 31.26 | 63.38 | 63.37 | -70.12 | 32.86 | 5.88 | -- | 0.0848 | 30.54 | -92.72 | 11.81 | -120.45 | -- | 2.43 | -- |
| Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd | 4.87bn | 2.57bn | 55.92bn | 219.00 | 21.78 | 2.50 | 20.71 | 11.49 | 0.6886 | 0.6886 | 1.31 | 6.01 | 0.2025 | 0.6403 | 7.16 | -- | 10.68 | -- | 11.59 | -- | 89.26 | -- | 52.72 | -- | 5.34 | -- | 0.0014 | -- | 31.58 | -- | 864.81 | -- | -- | -- |
| Zhejiang Gongdong Medical Techno Co Ltd | 12.77bn | 1.71bn | 56.09bn | 1.67k | 32.69 | 2.76 | -- | 4.39 | 0.9128 | 0.9128 | 6.81 | 10.81 | 0.5648 | 6.35 | 4.45 | 639,547.00 | 7.57 | 16.35 | 8.43 | 19.26 | 32.08 | 41.19 | 13.40 | 21.62 | 4.00 | -- | 0.0195 | 38.99 | -33.61 | 15.11 | -66.53 | 5.14 | 27.71 | -- |
| Hangzhou Alltest Biotech Co Ltd | 9.11bn | 2.78bn | 56.31bn | 1.09k | 20.27 | 1.21 | -- | 6.18 | 2.94 | 2.94 | 9.55 | 49.08 | 0.186 | 2.04 | 7.15 | 698,401.60 | 5.68 | 23.35 | 6.16 | 26.83 | 52.07 | 58.34 | 30.52 | 39.07 | 7.98 | -- | 0.0027 | 29.79 | -77.73 | 32.59 | -84.75 | 26.19 | 72.77 | -- |
| Entero Healthcare Solutions Ltd | -100.00bn | -100.00bn | 57.16bn | 3.24k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 18.85 | -- | 438.40 | -- | -- | -- |
| Shanghai Aohua Phtlctrcty Endscp Co Ltd | 8.86bn | 303.41m | 58.76bn | 1.09k | 199.88 | 3.53 | -- | 6.63 | 0.1831 | 0.1831 | 5.32 | 10.37 | 0.4712 | 0.9913 | 3.39 | 679,963.60 | 1.81 | 4.37 | 2.01 | 4.80 | 70.86 | 69.25 | 3.85 | 10.91 | 4.56 | -- | 0.0475 | 31.51 | 52.29 | 34.25 | 166.42 | -- | 20.42 | -- |
| HOGY MEDICAL CO., LTD. | 22.61bn | 1.69bn | 60.26bn | 1.41k | 38.43 | 1.29 | 11.23 | 2.67 | 120.47 | 120.47 | 1,612.79 | 3,596.36 | 0.3879 | 2.74 | 3.11 | 27,802,560.00 | 2.89 | 4.24 | 3.16 | 4.67 | 32.88 | 39.76 | 7.45 | 11.58 | 4.17 | -- | 0.0559 | 45.68 | 0.3053 | 1.30 | -35.03 | -14.24 | 7.94 | 4.56 |
Data as of Sep 27 2024. Currency figures normalised to Entero Healthcare Solutions Ltd's reporting currency: Indian Rupee INR
51.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| OrbiMed Advisors LLCas of 15 Feb 2024 | 16.54m | 38.03% |
| Capital Research & Management Co. (World Investors)as of 15 Feb 2024 | 1.35m | 3.11% |
| Millennium Management LLCas of 15 Feb 2024 | 1.26m | 2.90% |
| TT International Asset Management Ltd.as of 30 Apr 2024 | 939.91k | 2.16% |
| Invesco Asset Management (India) Pvt Ltd.as of 31 Aug 2024 | 611.91k | 1.41% |
| Jupiter Asset Management Ltd.as of 31 May 2024 | 425.32k | 0.98% |
| ICICI Prudential Asset Management Co. Ltd.as of 31 Jul 2024 | 415.82k | 0.96% |
| Amundi (UK) Ltd.as of 31 Jul 2024 | 287.69k | 0.66% |
| TT International (Hong Kong) Ltd.as of 30 Jun 2024 | 269.63k | 0.62% |
| Carmignac Gestion SAas of 30 Aug 2024 | 200.00k | 0.46% |
More ▼
Data from 30 Jun 2024 - 15 Sep 2024Source: FactSet Research Systems Inc.
